Login Register
English
0

Cart

$ 0
OR
Catalog no Product name Protocol name IF Magazine title
A23210 DyLight 488, Goat Anti-Mouse IgG Inhibiting UPF1 methylation enhances tumor immunotherapy sensitivity by reducing nonsense-mediated mRNA decay.(A23210-6.9) 6.9 Cell Reports 
ABL1060 Anti-COX IV Mouse Monoclonal Antibody (14Y2) Inhibition of AKT induces p53/SIRT6/PARP1-dependent parthanatos to suppress tumor growth(ABL1060-4) 4 Cell Commun Signal
A21010 HRP, Goat Anti-Mouse IgG Inhibition of AKT induces p53/SIRT6/PARP1-dependent parthanatos to suppress tumor growth(A21010-4) 4 Cell Commun Signal
ABL1070 Anti-Histone H3 Mouse Monoclonal Antibody (2D10) Inhibition of AKT induces p53/SIRT6/PARP1-dependent parthanatos to suppress tumor growth(ABL1070-4) 4 Cell Commun Signal
A21020 HRP, Goat Anti-Rabbit IgG Inhibition of AKT induces p53/SIRT6/PARP1-dependent parthanatos to suppress tumor growth(A21020-4) 4 Cell Commun Signal
ABL1020 Anti-GAPDH Mouse Monoclonal Antibody (2B5) Inhibition of angiogenesis in HUVECs by a novel cell-penetrating peptide-siVEGF complex(ABL1020-) J Pineal Res
A23220 Dylight 488, Goat Anti-Rabbit IgG Inhibition of Blood-Brain Barrier Disruption by an Apolipoprotein E-Mimetic Peptide Ameliorates Early Brain Injury in Experimental Subarachnoid Hemorrhage(A23220-5) 5 Translational Stroke Research
A23230 Dylight 488, Rabbit Anti-Goat IgG Inhibition of blood-brain barrier disruption by an apolipoprotein E-mimetic peptide ameliorates early brain injury in experimental subarachnoid hemorrhage(A23230-4) 4 Virologica Sinica
A23410 Dylight 594, Goat Anti-Mouse IgG Inhibition of Blood-Brain Barrier Disruption by an Apolipoprotein E-Mimetic Peptide Ameliorates Early Brain Injury in Experimental Subarachnoid Hemorrhage(A23410-5) 5 Translational Stroke Research
ABL1010 Anti-β-Actin Mouse Monoclonal Antibody (1C7) Inhibition of Blood-Brain Barrier Disruption by an Apolipoprotein E-Mimetic Peptide Ameliorates Early Brain Injury in Experimental Subarachnoid Hemorrhage(ABL1010-4) 4 Fish & shellfish immunology 55 (2016): 729-736